AVEO Pharmaceuticals CEO Michael Bailey's 2021 pay jumps 84% to $2.9M
AVEO Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
AVEO Pharmaceuticals reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, four executives at AVEO Pharmaceuticals received on average a compensation package of $1.7M, a 85% increase compared to previous year.
Average pay of disclosed executives at AVEO Pharmaceuticals
Michael Bailey, Chief Executive Officer, received $2.9M in total, which increased by 84% compared to 2020. 67% of Bailey's compensation, or $2M, was in option awards. Bailey also received $308K in non-equity incentive plan, $590K in salary, as well as $69K in other compensation.
For fiscal year 2021, the median employee pay was $278,596 at AVEO Pharmaceuticals. Therefore, the ratio of Michael Bailey's pay to the median employee pay was 11 to one.
Michael Needle, Chief Medical Officer, received a compensation package of $1.4M, which increased by 70% compared to previous year. 51% of the compensation package, or $719K, was in option awards.
Michael Ferraresso, Chief Commercial Officer, earned $1.3M in 2021, a 77% increase compared to previous year.
Erick Lucera, Chief Financial Officer, received $1.2M in 2021, which increases by 59% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 26, 2022.